My Policy Hub

Improving health is our policy

  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact
  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact

WHG - WHG Chart: Key Legislation on Raising the Tobacco Sale Age to 21

May 29, 2019

Summary

In the attached chart, we provide side-by-side analysis of the major Congressional (Senate and House) legislation intended to reduce youth tobacco use that have been introduced/released thus far in the 116th Congress.

For each of the four proposals outlined below, the chart examines key provisions regarding tobacco products, restrictions, new enforcement authority, user fees, and preemption. Specifically, we look at:

  • Tobacco-Free Youth Act (S. 1541): Raises the minimum legal tobacco sale age to 21. Authorizes the Secretary of Health and Human Services (HHS) to require states pass individual laws raising the minimum legal sale age to 21 in order to receive grants to support substance abuse prevention and treatment activities.
  • Tobacco to 21 Act (S. 1258/H.R. 2411): Raises the minimum legal tobacco sale age to 21 and prohibits the sale of tobacco products to individuals under 30 without age verification. Provides HHS Secretary with additional enforcement authority.
  • Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339): Raises the minimum legal tobacco sale age to 21. Prohibits remote retail sale of all tobacco products; flavoring of tobacco products unless intended to decrease smoking among current users; and advertising of electronic cigarettes under 21. Provides HHS Secretary with additional enforcement authority.
  • Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019 (H.R. 2084): Raises the minimum legal sale age to 21 and requires age verification for remote sale of tobacco products. Provides HHS Secretary with additional enforcement authority.

Given the high level of attention on this issue, including from Senate Majority Leader Mitch McConnell (R-KY) who sponsored S. 1541, we expect legislative action on this front in the coming months.

Read Full Analysis
Source
  • Wynne Health Group
Author(s)
  • Alyssa Llamas
Healthcare Topics
  • Food and Drug Administration
  • Public Health

ABOUT

  • Home
  • About Policy Hub
  • Free Newsletter
  • Team
  • Mission and Values
  • Contact Us

Contact Us

Impact Health Policy Partners 1301 K Street, NW, Suite 300W
Washington, D.C. 20005

(202) 309-0796
Contact Us

Copyright © 2025 ‐ Impact Health Policy Partners ‐ All Rights Reserved ‐ Privacy Policy ‐ Terms and Conditions ‐ Log in